The Institute of Cancer Research, London, has secured a £30 million grant from the Higher Education Funding Council for England (HEFCE) towards the costs of building a new, state-of-the-art drug discovery facility.
The grant is a major step forward for plans to build the £75 million Centre for Cancer Drug Discovery, which will form a key part of The London Cancer Hub.
The award was made as part of the UK Research Partnership Investment Fund scheme (UKRPIF), led by HEFCE, which provides investment for a range of innovative and exciting projects at universities across the UK.
The centre will offer more than 7,000 square metres of multidisciplinary research space, housing cancer biologists, medicinal chemists, pharmacologists, clinicians, data scientists and evolutionary scientists.
Responding to news of the award, Professor Paul Workman, Chief Executive of the ICR, said:
“We’re delighted and extremely grateful to have received a £30 million funding award from HEFCE towards creation of a new Centre for Cancer Drug Discovery.
“Getting this award is a major step forward for our ambitious plans to discover a new generation of innovative cancer treatments that tackle the major clinical challenges of cancer evolution and drug resistance.
Luke Johnson, Chairman of the ICR said: “This is a defining moment in the ICR’s 108-year history. Thanks to this £30 million grant, we shall shortly embark on the construction of a world-beating new facility in Sutton. It will house more than 275 multidisciplinary scientists discovering new drugs to defeat cancer.”
Announcing the award as part of a £177m investment in nine new projects, Universities and Science Minister Jo Johnson said:
“The UK’s world-renowned leadership in science, research and innovation is helping to solve a range of national and global challenges, and the breadth of the projects funded today means this will continue.
“Through our Industrial Strategy and £4.7 billion investment for research and development, we’re ensuring we capitalise on the great work taking place in universities across the UK and remain at the forefront of innovation.”